Skip to main content

Mismatch Repair Germline Pathogenic Variants Could Predispose to Uveal Melanoma

Medically reviewed by Carmen Pope, BPharm. Last updated on June 20, 2025.

via HealthDay

FRIDAY, June 20, 2025 -- Mismatch repair (MMR) germline alterations are enriched among patients with uveal melanoma (UM), according to a study published online June 18 in JAMA Ophthalmology.

Anaïs Le Ven, from Inserm U1339 in Paris, and colleagues conducted a prospective cohort study involving 381 consecutive patients diagnosed with UM between July 2021 and February 2023 to identify new genetic alterations predisposing for UM. All participants consented to extended genetic testing; a panel of 122 genes predisposing to cancer were analyzed by targeted sequencing on germline DNA.

The researchers identified 79 pathogenic variants (PVs) in 70 participants. Twenty-one of these were found in clinically relevant genes, with an enrichment in the MMR genes, involved in Lynch syndrome, suggesting that MMR germline PVs could predispose to UM. One tumor from a participant carrying an MLH1 germline PV exhibited a monosomy 3, with loss of the wild-type allele of MLH1, which is located on chromosome 3. Loss of MLH1 expression was seen by immunohistochemistry; whole-genome sequencing of this tumor identified MMR variant signatures SBS6, ID1, and ID2.

"These findings suggest that MMR germline alterations could explain at least a portion of UM genetics, and that UM could be part of the Lynch syndrome spectrum," the authors write.

One author disclosed ties to the pharmaceutical industry; a second author holds related patents.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Globally, Diabetes Underdiagnosed, Poorly Controlled With Treatment

MONDAY, Sept. 15, 2025 -- In 2023, 55.8 percent of those with diabetes were diagnosed, and 41.6 percent had optimal glycemic concentrations on treatment, according to a study...

2016 to 2023 Saw Decline in U.S. Pediatric Radiologists

MONDAY, Sept. 15, 2025 -- The number of U.S. pediatric radiologists declined from 2016 to 2023, according to a study published online Sept. 9 in the Journal of the American...

Machine, Deep Learning Models Improve Prediction of CKD Progression

MONDAY, Sept. 15, 2025 -- Machine learning and deep learning models applied to integrated clinical and claims data can improve prediction of chronic kidney disease (CKD)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.